Improving Outcomes in Bipolar Disorder Through Community Pharmacist Interventions

Pharmacy Times, March 2015 Central Nervous System, Volume 81, Issue 3

This activity is supported by an educational grant from Sunovion Pharmaceuticals, Inc.

Improving Outcomes in Bipolar Disorder Through Community Pharmacist Interventions

Faculty

Megan Maroney, PharmD, BCPP

Clinical Assistant Professor

Department of Pharmacy Practice and Administration

Ernest Mario School of Pharmacy

Rutgers, the State University of New Jersey

Clinical Psychiatric Pharmacist

Monmouth Medical Center

Long Branch, New Jersey

Activity Overview

Bipolar disorder affects approximately 60 million people worldwide and ranks as the 12th leading cause of disability globally. This continuing education activity is designed to discuss the features and impact of bipolar disorder, summarize the treatment landscape and pipeline activity for the disease, and describe effective counseling strategies that pharmacists can employ.

Educational Objectives:

After completing this continuing education program, the participant will be able to:

  • Discuss the disabling features of bipolar disorder and its significant impact on patients and society.
  • Summarize the expansive treatment landscape for bipolar disorder and the role of emerging agents.
  • Describe effective counseling strategies that pharmacists can employ for patients with bipolar disorder.

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

March 6, 2015

Expiration date:

March 6, 2017

Estimated time to complete activity:

2.0 hours

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-012-H01-P. The activity is available for CE credit through March 6, 2017.